Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV(POS) Cancers

por Suksanpaisan, Lukkana, Xu, Rong, Tesfay, Mulu Z., Bomidi, Carolyn, Hamm, Stefan, Vandergaast, Rianna, Jenks, Nathan, Steele, Michael B., Ota-Setlik, Ayuko, Akhtar, Hinna, Luckay, Amara, Nowak, Rebecca, Peng, Kah Whye, Eldridge, John H., Clarke, David K., Russell, Stephen J., Diaz, Rosa Maria
Publicado 2018

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy

por Zhang, Yuguo, Gabere, Musa, Taylor, Mika A., Simoes, Camila C., Dumbauld, Chelsae, Barro, Oumar, Tesfay, Mulu Z., Graham, Alicia L., Ferdous, Khandoker Usran, Savenka, Alena V., Chamcheu, Jean Christopher, Washam, Charity L., Alkam, Duah, Gies, Allen, Byrum, Stephanie D., Conti, Matteo, Post, Steven R., Kelly, Thomas, Borad, Mitesh J., Cannon, Martin J., Basnakian, Alexei, Nagalo, Bolni M.
Publicado 2022